Salvianolic acid�B protects against sepsis‑induced liver injury via activation of SIRT1/PGC‑1α signaling
Hongling Su(Gansu Provincial Hospital), Xiangmin Yang(National Medical Products Administration)
Cited by 21
Related Papers
Safety and efficacy of meplazumab in healthy volunteers and COVID-19 patients: a randomized phase 1 and an exploratory phase 2 trial
|Signal Transduction and Targeted Therapy|2021|66